| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000006220 |
| Receipt No. | R000007364 |
| Official scientific title of the study | Influence of method to administer lidocaine into trachea |
| Date of disclosure of the study information | 2011/08/23 |
| Last modified on | 2016/04/03 (Ver. 7) |
| Basic information | ||
| Official scientific title of the study | Influence of method to administer lidocaine into trachea | |
| Title of the study (Brief title) | Influence of method to administer lidocaine into trachea | |
| Region |
|
|
| Condition | ||
| Condition | patient undergoing elective surgery under general anesthesia | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The aim is to examine the effect of method to administer lidocaine into trachea on pharmacokinetics of lidocaine. |
| Basic objectives2 | Pharmacokinetics |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | plasma concentration of lidocaine |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | conventional device for tracheal administration | |
| Interventions/Control_2 | novel device for tracheal administration | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | patients undergoing elective surgery under general anesthesia | |||
| Key exclusion criteria | significant heart, respiratory, hepatic, or renal impairment; body mass index greater than 30 | |||
| Target sample size | 50 | |||
| Research contact person | |
| Name of lead principal investigator | Kenichi Masui |
| Organization | National Defense Medical College Hospital |
| Division name | Department of Anesthesiology |
| Address | Namiki 3-2, Tokorozawa, Saitama, Japan |
| TEL | 04-2995-1511 |
| kenichi@masuinet.com | |
| Public contact | |
| Name of contact person | Kenichi Masui |
| Organization | National Defense Medical College |
| Division name | Department of Anesthesiology |
| Address | Namiki 3-2, Tokorozawa, Saitama, Japan |
| TEL | 04-2995-1511 |
| Homepage URL | |
| kenichi@masuinet.com | |
| Sponsor | |
| Institute | National Defense Medical College |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | National Defense Medical College and
Departmental Funding |
| Organization | |
| Division | |
| Category of Funding Organization | |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-bin/ctr_e/ctr_view.cgi?recptno=R000007364 |